Skip to content

Pilot Study About Tamoxifen Therapy for Breast Cancer Patients

Pilot Study to Evaluate the Knowledge and Understanding on Tamoxifen Therapy for Breast Cancer Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02094495
Enrollment
300
Registered
2014-03-21
Start date
2014-06-30
Completion date
2017-03-31
Last updated
2014-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Tamoxifen, Breast cancer, Knowkedge

Brief summary

The aim of this study are to to evaluate the knowledge and understanding on tamoxifen theraphy for breast cancer patients and examine the decision conflict scale and satisfaction with decision scale while making decision to take tamoxifen.

Detailed description

The knowlege questionnaire about tamoxifen was developed by the medication guides that provide for patients taking tamoxifen and hormone therapy for breast cancer fact sheet from National Cancaer Institute. Several experts in the field of breast cancer and gynecologic cancer are going to review and indicate the questionnaire.

Interventions

None listed

Sponsors

National Cancer Center, Korea
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The breast cancer patients who take tamoxifen

Design outcomes

Primary

MeasureTime frameDescription
The knowledge questionnaire about tamoxifenThe study outcome measure will be assessed by face-to-face, one time.There are no more follow up except one time

Secondary

MeasureTime frameDescription
Decision Conflict ScaleThe study outcome measure will be assessed by face-to-face , one time.There are no more follow up except one time.

Other

MeasureTime frameDescription
1. Satisfaction with Decision scaleThe study outcome measure will be assessed by face-to-face , one time.There are no more follow up except one time
Quality of life (EQ-5D, VAS)The study outcome measure will be assessed by face-to-face, one time.
Female Sexual Function Index - 6 items, Korean versionThe study outcome measure will be assessed by face-to-face, one time.

Countries

South Korea

Contacts

Primary ContactEun Sook Lee, MD, PhD
eslee@ncc.re.kr+82-31-920-2011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026